(Q34985529)

5 August 2017

1 reference

title

Recent advances in the development of selective androgen receptor modulators (English)

1 reference

5 August 2017

Xuqing Zhang

1

1 reference

5 August 2017

James C Lanter

series ordinal

2

1 reference

5 August 2017

Zhihua Sui

series ordinal

3

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

Expert Opinion on Therapeutic Patents

5 August 2017

published in

1 reference

5 August 2017

volume

19

1 reference

5 August 2017

issue

9

1 reference

5 August 2017

page(s)

1239-1258

1 reference

Biological Actions of Androgens

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Androgens in men--uses and abuses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Pharmacotherapy of osteoporosis in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Androgen replacement therapy in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Study of 202 Natural, Synthetic, and Environmental Chemicals for Binding to the Androgen Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Discovery of nonsteroidal androgens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer. Casodex Combination Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Therapeutic androgen receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Chemistry and structural biology of androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Discovery and therapeutic promise of selective androgen receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Non-steroidal steroid receptor modulators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Therapeutic potential of the SARMs: revisiting the androgen receptor for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Selective androgen receptor modulators in drug discovery: medicinal chemistry and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Pharmacodynamics of selective androgen receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Pharmacokinetics of S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro- 3-trifluoromethyl-phenyl)-propionamide in rats, a non-steroidal selective androgen receptor modulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

In vivo metabolism and final disposition of a novel nonsteroidal androgen in rats and dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

A selective androgen receptor modulator for hormonal male contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Preclinical characterization of a (S)-N-(4-cyano-3-trifluoromethyl-phenyl)-3-(3-fluoro, 4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide: a selective androgen receptor modulator for hormonal male contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Discovery of potent, orally-active, and muscle-selective androgen receptor modulators based on an N-aryl-hydroxybicyclohydantoin scaffold

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Synthesis and SAR of tetrahydropyrrolo[1,2-b][1,2,5]thiadiazol-2(3H)-one 1,1-dioxide analogues as highly potent selective androgen receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Discovery of a potent, orally active, nonsteroidal androgen receptor agonist: 4-ethyl-1,2,3,4-tetrahydro-6- (trifluoromethyl)-8-pyridono[5,6-g]- quinoline (LG121071).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Discovery of an androgen receptor modulator pharmacophore based on 2-quinolinones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Discovery of 6-N,N-bis(2,2,2-trifluoroethyl)amino- 4-trifluoromethylquinolin-2(1H)-one as a novel selective androgen receptor modulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Substituted 6-(1-pyrrolidine)quinolin-2(1H)-ones as novel selective androgen receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Structure of the ligand-binding domain (LBD) of human androgen receptor in complex with a selective modulator LGD2226

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Pharmacokinetics and pharmacodynamics of LGD-3303 [9-chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-3H-pyrrolo-[3,2-f]quinolin-7(6H)-one], an orally available nonsteroidal-selective androgen receptor modulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-ones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Potent, nonsteroidal selective androgen receptor modulators (SARMs) based on 8H-[1,4]oxazino[2,3-f]quinolin-8-ones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Discovery of a novel series of nonsteroidal androgen receptor modulators: 5- or 6-oxachrysen-2-ones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Bone Anabolic Effects of S-40503, a Novel Nonsteroidal Selective Androgen Receptor Modulator (SARM), in Rat Models of Osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Design, synthesis, and in vivo SAR of a novel series of pyrazolines as potent selective androgen receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

A selective androgen receptor modulator with minimal prostate hypertrophic activity enhances lean body mass in male rats and stimulates sexual behavior in female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Serendipitous discovery of novel imidazolopyrazole scaffold as selective androgen receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

A selective androgen receptor modulator with minimal prostate hypertrophic activity restores lean body mass in aged orchidectomized male rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

A selective androgen receptor modulator that reduces prostate tumor size and prevents orchidectomy-induced bone loss in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

Pharmacological characterization of AC-262536, a novel selective androgen receptor modulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770902994397

10.1517/13543770902994397

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference